Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)
Clinical trial NCT03534492 · COMPLETED
Trial details
- NCT number
- NCT03534492
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-16
- Primary completion
- 2020-03-16
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.